Literature DB >> 12812893

Digital analysis of choroidal neovascularisation in consecutive fluorescein angiograms for use in longitudinal clinical trials.

C Bellmann1, D W Miller, K Mehltretter, F Schütt, J Jorzik, K Unnebrink, F G Holz.   

Abstract

BACKGROUND/AIMS: To document the natural history and to assess the efficacy of interventional therapies in neovascular age related macular degeneration (AMD), an accurate and reproducible method is required for analysis of consecutive fluorescence angiograms. The development and evaluation of an image analysis software for this purpose is described here. It allows for the quantitative analysis of changes in CNV and/or leakage area over time.
METHODS: In digitised angiograms, a mouse driven arrow was used to delineate the CNV border. The ratio of the CNV area to the square of the distance between two vessels was automatically calculated by pixel count to compensate for variation in image sizes at different examination times. These results were directly transferred and stored in a database. To assess reproducibility, CNV areas in 20 patients with occult and 20 patients with classic CNV were determined independently by two readers.
RESULTS: There was only marginal variability between observers with this method: the mean deviation was 0.01 pixels for classic CNV (95% CI -0.17 to +0.15, SD 0.35) and 0.55 pixels for occult CNV (95% CI -1.06 to -0.04, SD 1.14).
CONCLUSIONS: This practical PC based method allows for quantification of angiographic features such as CNV size in early frames and area of leakage in late frames. Limitations include non-readily defined borders in angiograms of poor image quality or indistinct borders of the hyperfluorescent areas of interest. The software is applicable to future clinical trials where the analysis of neovascular complex changes is required, for example, following therapeutic intervention.

Entities:  

Mesh:

Year:  2003        PMID: 12812893      PMCID: PMC1771740          DOI: 10.1136/bjo.87.7.890

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  20 in total

1.  Optic disc photogrammetry: magnification factors for eye position, centration, and ametropias, refractive and axial; and their application in the diagnosis of optic nerve hypoplasia.

Authors:  J Pach; D O Pennell; P E Romano
Journal:  Ann Ophthalmol       Date:  1989-12

2.  A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration.

Authors: 
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-09

4.  The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group.

Authors:  J A Chamberlin; N M Bressler; S B Bressler; M J Elman; R P Murphy; T P Flood; B S Hawkins; M G Maguire; S L Fine
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Reliability of optic disk topographic measurements recorded with a video-ophthalmograph.

Authors:  F S Mikelberg; G R Douglas; M Schulzer; T N Cornsweet; K Wijsman
Journal:  Am J Ophthalmol       Date:  1984-07-15       Impact factor: 5.258

7.  [Determination of the real size of an object on the fundus of the living eye].

Authors:  H Littmann
Journal:  Klin Monbl Augenheilkd       Date:  1982-04       Impact factor: 0.700

8.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

9.  Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.

Authors:  J S Sunness; J Gonzalez-Baron; C A Applegate; N M Bressler; Y Tian; B Hawkins; Y Barron; A Bergman
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

Review 10.  Age-related macular degeneration.

Authors:  N M Bressler; S B Bressler; S L Fine
Journal:  Surv Ophthalmol       Date:  1988 May-Jun       Impact factor: 6.048

View more
  1 in total

1.  Added value of OCT in evaluating the presence of leakage in patients with age-related macular degeneration treated with PDT.

Authors:  M E J van Velthoven; M D de Smet; R O Schlingemann; M Magnani; F D Verbraak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-08       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.